Sanofi’s Sarclisa subcutaneous formulation administered via on-body injector recommended for EU approval by the CHMP to treat multiple myeloma Recommendation based on positive results demonstrating ...
The US Food and Drug Administration (FDA) has approved a new medical device, largely unremarkable but for one unusual aspect: It gives instructions to its administrator verbally. French life sciences ...
The U.S. Food and Drug Administration (FDA) on Wednesday delayed its decision on Sanofi SA’s SNY subcutaneous Sarclisa formulation while separately broadening the eligible patient population for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results